Cytely

Lund, Sweden Founded: 2022 • Age: 4 yrs
Smart microscopy platforms for biomedical cell analysis are provided.

About Cytely

Cytely is a Healthcare company based in Lund (Sweden) founded in 2022 by Johannes Ahnlide and Philip Nordenfelt. Smart microscopy platforms for biomedical cell analysis are provided. Cytely has raised $3.48 million across 2 funding rounds from investors including SmiLe Incubator, Icebreaker.vc and Ugly Duckling Ventures. Its chief executive, as recorded, is Philip Nordenfelt. Cytely offers products and services including Cytely Platform and CYTELY CLI. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Image Analysis. Its legal entity is Cytely AB.

Company details

Cytely was founded in 2022 in Lund, Sweden, within the biomedical research sector. A hardware-agnostic platform is offered that integrates with motorized microscopes to enable qualitative analysis of individual cells alongside high-resolution imaging of sample populations. The entire microscopy workflow, from image acquisition to real-time analysis, is automated through AI and machine learning technologies. Operations focus on enhancing research efficiency in cellular studies.

  • Headquarters Lund, Sweden
  • Founders Johannes Ahnlide, Philip Nordenfelt
  • Sectors
    Healthcare
  • Website cytely.io
  • Social LinkedIn X YouTube
  • Legal Name Cytely Ab
Key Metrics
  • Total Equity Funding
    $3.48M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.48M (USD), Series A

    Oct 2025

  • Investors

Products & Services of Cytely

Cytely offers a comprehensive portfolio of products and services, including Cytely Platform and CYTELY CLI.

Cytely Platform
Microscopy Software

Automates data collection and analysis for scientific microscopy research.

CYTELY CLI
Command-Line Tool

Enables high-fidelity data processing in microscopy applications.

Apps and channels of Cytely

its YouTube channel Cytely has 45 subscribers.

Cytely
YouTube 45 subscribers Other
Open channel

Funding Insights of Cytely

Cytely has successfully raised a total of $3.48M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.48 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $3.48M
  • Total Rounds 2
  • Last Round Series A β€” $3.48M
  • Investors Count 3

All 2 funding rounds of Cytely with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025$3.48MSeries A–Ugly Duckling Ventures
Feb 2024Seed––
Valuation history

3 investors in total: 3 institutional.

Investors in Cytely

Cytely has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include SmiLe Incubator, Icebreaker.vc and Ugly Duckling Ventures.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Seed and early-stage tech investments are targeted in Finland.
icebreaker.vcHelsinki, Finland
Startup accelerator and incubator
2007smileventurehub.comLund, Sweden
uglyduckling.ventures
Premium access

Investor details for Cytely

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Cytely

2 people are tracked at Cytely (2 in leadership).

NameRoleGroup
Johannes Ahnlide
Co-Founder & CTOLeadership
Philip Nordenfelt
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Cytely

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Cytely

3 dated milestones of Cytely across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cytely is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series A, of $3.5M.

Web traffic of Cytely

The website of Cytely (cytely.io) receives about 2.3K visits a month.

  • Monthly visits
    2.3K

    ▲ 72.8% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cytely

Cytely was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Cytely is headquartered in Lund, Sweden.

Philip Nordenfelt is the CEO of Cytely, as recorded in our data. They have also founded this company.

Cytely is a funded company, having raised a total of $3.48M across 2 funding rounds to date.

Cytely was founded in 2022 in Lund, Sweden, within the biomedical research sector. A hardware-agnostic platform is offered that integrates with motorized microscopes to enable qualitative analysis of individual cells alongside high-resolution imaging of sample populations. The entire microscopy workflow, from image acquisition to real-time analysis, is automated through AI and machine learning technologies. Operations focus on enhancing research efficiency in cellular studies.

Cytely offers Cytely Platform and CYTELY CLI.

Cytely has 3 investors. Key investors include SmiLe Incubator, Icebreaker.vc, and Ugly Duckling Ventures.

Cytely operates through Cytely Ab.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available